CYCLOPHOSPHAMIDE , -, PREDNISONE , PREDNISOLONE , VINCRISTINE, DOXORUBICIN , RITUXIMAB , Zilovertamab vedotin
MK-2140-010
Phase 3 small_molecule active
Quick answer
CYCLOPHOSPHAMIDE , -, PREDNISONE , PREDNISOLONE , VINCRISTINE, DOXORUBICIN , RITUXIMAB , Zilovertamab vedotin for Diffuse Large B-Cell Lymphoma (DLBCL) is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active